Gentamicin marker genes for plant transformation
CA 1324096 C · Owner: Klee, Harry John · Inventors: Klee, Harry John; Rogers, Stephen Gary; Hayford, Maria Burmaz
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An improved method for selecting transformed plant cells is disclosed. The invention involves the use of a selectable plant marker gene encoding a gentamicin-3-N-acetyltransferase enzyme. The use of the gentamicin marker genes affords advantages over known markers in some plants. The invention also provides transformed plant cells that contain the gentamicin marker genes as well as differentiated plants containing transformed plant cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 9, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 9, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.